Developer docs
API playgroundTry for free, no card

Search company profiles

RxCrossroads

Full company profile

uuid003e4ef

Namestring
RxCrossroads
Legal namestring
RxCrossroads
Company typeenum
Private
Founded yearint
1986
Descriptiontext

RxCrossroads is a B2B hub services provider that connects patients with specialty pharmaceutical therapies, operating from Louisville, Kentucky with 10,000+ employees. The company delivers structured programs organized around four pillars — access, affordability, adherence, and analytics — covering benefits verification, prior authorization processing, copay assistance enrollment, adherence support, and temperature-controlled specialty drug distribution. Its primary customer segment is specialty pharmaceutical manufacturers developing high-cost therapies, including cell and gene therapy programs where RxCrossroads has over a decade of specialized experience.

The underlying technology stack combines benefits verification platforms, prior authorization processing systems, copay assistance enrollment tools, and temperature-controlled drug delivery infrastructure with cold-chain capabilities. RxCrossroads has accumulated 1.5M+ sq.ft. across its core distribution centers and operates within McKesson's Third Party Logistics network, which ships over 2 billion units annually at 99.98% accuracy. The model blends technology platforms with high-touch human patient support.

Commercially, RxCrossroads generates revenue as managed services fees from pharmaceutical manufacturer clients for hub program deployment and ongoing patient support. The company is privately held and has been a McKesson subsidiary since 2017, when McKesson acquired it from CVS Health. It sits within McKesson's Biopharma Capabilities segment alongside offerings in pharmaceutical distribution, oncology and multispecialty solutions, and prescription benefit solutions.

Short descriptiontext

RxCrossroads is a B2B hub services provider for specialty pharmaceutical manufacturers, delivering benefits verification, prior authorization, copay assistance, adherence support, and temperature-controlled drug distribution. Operating as a McKesson subsidiary since 2017, the Louisville-based company employs 10,000+ staff.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersLouisville, United States
HQ citystring
Louisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
specialty pharmaceutical hub services, patient access support, benefits verification services, prior authorization processing, specialty drug distribution
Industry3 codes
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYTLACAJAB
Pharmaceuticals & Life Sciences Forwarding (GxP/GDP)
Transportation & Logistics/Freight Forwarding & Customs Brokerage/Specialized Cargo Forwarding (Perishables/Pharma, Dangerous Goods, Live Animals)
NAICS code2 codes
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceutical Hub Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Hub Services Revenue
TypeManaged Services
Description

RxCrossroads generates revenue by providing hub services to specialty pharmaceutical manufacturers, including benefits verification, prior authorization support, copay assistance enrollment, and specialty drug distribution services.

pharmaceuticalcommerce.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RxCrossroads provides B2B hub services for specialty pharmaceutical manufacturers, structured around four pillars: access, affordability, adherence, and analytics. Its offerings include benefits verification, prior authorization processing, copay assistance enrollment, temperature-controlled specialty drug distribution (3PL), and patient adherence programs designed to help patients start and stay on complex, high-cost specialty medications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

RxCrossroads is a hub services provider that was acquired by McKesson from CVS Health. Based on industry context, RxCrossroads provides hub services and patient support solutions for the specialty pharmaceutical industry. However, the source data does not contain specific product details, service names, or descriptions of RxCrossroads's individual offerings.

Product and service5 records
1Benefits Verification
CategoryPatient Access Services
Description

Technology-enabled benefits verification service that streamlines insurance coverage confirmation for patients requiring specialty medications, offered to specialty pharmaceutical manufacturers.

2Prior Authorization Processing
CategoryPatient Access Services
Description

Service that handles prior authorization requirements between providers, payers, and manufacturers to reduce delays in patient access to specialty medications.

3Copay Assistance Enrollment
CategoryPatient Affordability Services
Description

Technology-enabled enrollment service for copay assistance programs that helps patients afford high-cost specialty medications, offered to specialty pharmaceutical manufacturers.

4Temperature-Controlled Specialty Drug Distribution
CategorySpecialty Pharmaceutical Logistics
Description

Specialized third-party logistics (3PL) service providing cold-chain capable, temperature-controlled distribution of specialty medications including cell and gene therapies, with more than 2 billion units shipped annually and 99.98% inventory and order accuracy rates through McKesson integration.

5Patient Adherence Programs
CategoryPatient Adherence Services
Description

High-touch support programs that help patients starting on specialty therapies to remain adherent to treatment, combining human outreach with analytics-driven patient journey insights.

Partnership1 partner
1McKesson
Strategic tierCoreTypeOthersAnnounced on2017-01-01
Description

McKesson acquired RxCrossroads from CVS Health in 2017, integrating the hub services provider into McKesson's Biopharma Capabilities segment. This acquisition provides RxCrossroads with access to McKesson's extensive pharmaceutical distribution network and supply chain infrastructure.

pharmaceuticalcommerce.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ConnectiveRx delivers manufacturer hub services including copay, benefit verification, and patient support programs for specialty brands — directly comparable to RxCrossroads' specialty manufacturer services.

TypeDirect peer
Description

CareMetx provides specialty hub, prior authorization, copay assistance, and adherence services to biopharma manufacturers — a near-direct competitor operating the same four-pillar (access, affordability, adherence, engagement) hub model.

3Sonexus Health
TypeDirect peer
Description

Sonexus Health (formerly part of Express Scripts/Medco) provides patient access and hub services for specialty pharma manufacturers, covering copay support, prior authorization, and adherence — a direct hub-services peer.

TypeBroad incumbent
Description

CVS Specialty is the specialty pharmacy and patient services arm of CVS Health — RxCrossroads' former parent — and a broad incumbent offering hub-adjacent services across payer, manufacturer, and dispensing relationships.

TypeBroad incumbent
Description

Optum Rx Specialty is UnitedHealth Group's specialty pharmacy and hub platform — a vertically integrated incumbent competing directly with RxCrossroads for manufacturer hub business.

TypeBroad incumbent
Description

Accredo is Express Scripts' specialty pharmacy and patient services arm covering distribution, hub, and adherence for high-cost therapies — a broader incumbent that competes for both manufacturer services and downstream specialty fulfillment.

TypeDirect peer
Description

Asembia is a leading specialty pharmacy hub services provider working with biopharma manufacturers on patient access, copay, and adherence programs — directly comparable to RxCrossroads' hub offering across manufacturers and therapies.

TypeDirect peer
Description

Eversana's Lash Group provides patient services and hub solutions for biopharma manufacturers; comparable to RxCrossroads across patient access, adherence, and specialty distribution support.

TypeBroad incumbent
Description

Walgreens Specialty Pharmacy combines specialty distribution with manufacturer hub-adjacent services for oncology, autoimmune, and other high-cost therapies — comparable to RxCrossroads on the fulfillment-plus-support combined offering.

10McKesson Biopharma Capabilities
TypeBroad incumbent
Description

McKesson's Biopharma Capabilities segment — RxCrossroads' own parent business — competes at a broader scale than RxCrossroads alone and is the closest internal-comparable divisional reference for the services RxCrossroads provides.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxCrossroads

Specialty Pharmaceutical Hub Servicesrxcrossroads.com

RxCrossroads is a B2B hub services provider for specialty pharmaceutical manufacturers, delivering benefits verification, prior authorization, copay assistance, adherence support, and temperature-controlled drug distribution. Operating as a McKesson subsidiary since 2017, the Louisville-based company employs 10,000+ staff.

What RxCrossroads does

RxCrossroads is a B2B hub services provider that connects patients with specialty pharmaceutical therapies, operating from Louisville, Kentucky with 10,000+ employees. The company delivers structured programs organized around four pillars — access, affordability, adherence, and analytics — covering benefits verification, prior authorization processing, copay assistance enrollment, adherence support, and temperature-controlled specialty drug distribution. Its primary customer segment is specialty pharmaceutical manufacturers developing high-cost therapies, including cell and gene therapy programs where RxCrossroads has over a decade of specialized experience.

The underlying technology stack combines benefits verification platforms, prior authorization processing systems, copay assistance enrollment tools, and temperature-controlled drug delivery infrastructure with cold-chain capabilities. RxCrossroads has accumulated 1.5M+ sq.ft. across its core distribution centers and operates within McKesson's Third Party Logistics network, which ships over 2 billion units annually at 99.98% accuracy. The model blends technology platforms with high-touch human patient support.

Commercially, RxCrossroads generates revenue as managed services fees from pharmaceutical manufacturer clients for hub program deployment and ongoing patient support. The company is privately held and has been a McKesson subsidiary since 2017, when McKesson acquired it from CVS Health. It sits within McKesson's Biopharma Capabilities segment alongside offerings in pharmaceutical distribution, oncology and multispecialty solutions, and prescription benefit solutions.

RxCrossroads firmographics

Firmographics
Name
RxCrossroads
Legal name
RxCrossroads
Website
https://rxcrossroads.com
Company type
Private
Founded year
1986
Operating status
Acquired
Headcount range
10,001+ employees
Short description
RxCrossroads is a B2B hub services provider for specialty pharmaceutical manufacturers, delivering benefits verification, prior authorization, copay assistance, adherence support, and temperature-controlled drug distribution. Operating as a McKesson subsidiary since 2017, the Louisville-based company employs 10,000+ staff.
Ownership category
akta.pro rank

RxCrossroads industry classification

Industry
Product category
Specialty Pharmaceutical Hub Services
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAKAG
Patient Access Programs & Affordability (Copay/Hubs/PSP)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAFALAJ
Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYTLACAJAB
Pharmaceuticals & Life Sciences Forwarding (GxP/GDP)
Transportation & Logistics/Freight Forwarding & Customs Brokerage/Specialized Cargo Forwarding (Perishables/Pharma, Dangerous Goods, Live Animals)

Keywords

  • Specialty pharmaceutical hub services
  • Patient access support
  • Benefits verification services
  • Prior authorization processing
  • Specialty drug distribution

Where RxCrossroads is headquartered

Location

Headquarters

HQ city
Louisville
HQ country
United States
HQ region
North America

Markets served

RxCrossroads business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Hub Services Revenue: RxCrossroads generates revenue by providing hub services to specialty pharmaceutical manufacturers, including benefits verification, prior authorization support, copay assistance enrollment, and specialty drug distribution services.

Go-to-market motion1 record

Distribution channels1 record

RxCrossroads product offering

Product offering

Core offering

RxCrossroads provides B2B hub services for specialty pharmaceutical manufacturers, structured around four pillars: access, affordability, adherence, and analytics. Its offerings include benefits verification, prior authorization processing, copay assistance enrollment, temperature-controlled specialty drug distribution (3PL), and patient adherence programs designed to help patients start and stay on complex, high-cost specialty medications.

Product overview

RxCrossroads is a hub services provider that was acquired by McKesson from CVS Health. Based on industry context, RxCrossroads provides hub services and patient support solutions for the specialty pharmaceutical industry. However, the source data does not contain specific product details, service names, or descriptions of RxCrossroads's individual offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Benefits Verification Technology-enabled benefits verification service that streamlines insurance coverage confirmation for patients requiring specialty medications, offered to specialty pharmaceutical manufacturers.
  • Prior Authorization Processing Service that handles prior authorization requirements between providers, payers, and manufacturers to reduce delays in patient access to specialty medications.
  • Copay Assistance Enrollment Technology-enabled enrollment service for copay assistance programs that helps patients afford high-cost specialty medications, offered to specialty pharmaceutical manufacturers.
  • Temperature-Controlled Specialty Drug Distribution Specialized third-party logistics (3PL) service providing cold-chain capable, temperature-controlled distribution of specialty medications including cell and gene therapies, with more than 2 billion units shipped annually and 99.98% inventory and order accuracy rates through McKesson integration.
  • Patient Adherence Programs High-touch support programs that help patients starting on specialty therapies to remain adherent to treatment, combining human outreach with analytics-driven patient journey insights.

Companies that use RxCrossroads

Customer profile

Segments1 record

Ideal customer profiles1 record

RxCrossroads technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

RxCrossroads partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • McKessoncoreOthers · 1 January 2017McKesson acquired RxCrossroads from CVS Health in 2017, integrating the hub services provider into McKesson's Biopharma Capabilities segment. This acquisition provides RxCrossroads with access to McKesson's extensive pharmaceutical distribution network and supply chain infrastructure.

Recent moves4 records

Expansion highlights4 records

RxCrossroads competitors and assessment

Company assessment

Direct peers

  • ConnectiveRx: ConnectiveRx delivers manufacturer hub services including copay, benefit verification, and patient support programs for specialty brands — directly comparable to RxCrossroads' specialty manufacturer services.
  • CareMetx: CareMetx provides specialty hub, prior authorization, copay assistance, and adherence services to biopharma manufacturers — a near-direct competitor operating the same four-pillar (access, affordability, adherence, engagement) hub model.
  • Sonexus Health: Sonexus Health (formerly part of Express Scripts/Medco) provides patient access and hub services for specialty pharma manufacturers, covering copay support, prior authorization, and adherence — a direct hub-services peer.
  • Asembia: Asembia is a leading specialty pharmacy hub services provider working with biopharma manufacturers on patient access, copay, and adherence programs — directly comparable to RxCrossroads' hub offering across manufacturers and therapies.
  • Eversana (Lash Group): Eversana's Lash Group provides patient services and hub solutions for biopharma manufacturers; comparable to RxCrossroads across patient access, adherence, and specialty distribution support.

Broad incumbents

  • CVS Specialty (CVS Health): CVS Specialty is the specialty pharmacy and patient services arm of CVS Health — RxCrossroads' former parent — and a broad incumbent offering hub-adjacent services across payer, manufacturer, and dispensing relationships.
  • Optum Rx Specialty: Optum Rx Specialty is UnitedHealth Group's specialty pharmacy and hub platform — a vertically integrated incumbent competing directly with RxCrossroads for manufacturer hub business.
  • Accredo (Express Scripts): Accredo is Express Scripts' specialty pharmacy and patient services arm covering distribution, hub, and adherence for high-cost therapies — a broader incumbent that competes for both manufacturer services and downstream specialty fulfillment.
  • Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy combines specialty distribution with manufacturer hub-adjacent services for oncology, autoimmune, and other high-cost therapies — comparable to RxCrossroads on the fulfillment-plus-support combined offering.
  • McKesson Biopharma Capabilities: McKesson's Biopharma Capabilities segment — RxCrossroads' own parent business — competes at a broader scale than RxCrossroads alone and is the closest internal-comparable divisional reference for the services RxCrossroads provides.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

RxCrossroads financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxCrossroads leadership team

Management profile

Number of profiles

RxCrossroads funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxCrossroads M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxCrossroads

What does RxCrossroads do?

RxCrossroads provides B2B hub services for specialty pharmaceutical manufacturers, structured around four pillars: access, affordability, adherence, and analytics. Its offerings include benefits verification, prior authorization processing, copay assistance enrollment, temperature-controlled specialty drug distribution (3PL), and patient adherence programs designed to help patients start and stay on complex, high-cost specialty medications.

Is RxCrossroads a public or private company?

RxCrossroads is a private company. It is classified as corporate owned and is currently acquired.

When was RxCrossroads founded?

RxCrossroads was founded in 1986. It employs 10,001+ people.

Where is RxCrossroads based?

RxCrossroads is headquartered in Louisville, United States, in the North America region.

How does RxCrossroads make money?

One revenue line is on record: hub Services Revenue.

Who are RxCrossroads's main competitors?

Direct peers on record are ConnectiveRx, CareMetx, Sonexus Health, Asembia and Eversana (Lash Group). Broad incumbents are CVS Specialty (CVS Health), Optum Rx Specialty, Accredo (Express Scripts), Walgreens Specialty Pharmacy and McKesson Biopharma Capabilities.

Does RxCrossroads have an API?

No public API is recorded for RxCrossroads.

What industry is RxCrossroads in?

RxCrossroads's product category is Specialty Pharmaceutical Hub Services. Its primary akta.pro industry code is HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP), with a secondary code of HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 524292 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmaCommerceThe Hub Services Wheel keeps Rolling AlongThe article examines the growth and increasing competition in hub services and patient support providers serving the specialty pharmaceutical industry, noting continued private equity investment and business realignments in 2017. Key transactions include the sale of Dohmen Life Sciences Services to Water Street Healthcare Partners and JLL Partners, and McKesson's acquisition of RxCrossroads from CVS Health. The piece profiles multiple industry participants including TrialCard, Triplefin, PharmaCord, and CoverMyMeds, discussing their service models, technology platforms, and positioning within the evolving hub services ecosystem.Business Wire BlogAMP: Access for More Patients™ Transforms Patient Access to Specialty MedicationsRxCrossroads by McKesson and CoverMyMeds launched AMP, a technology-driven patient support solution for specialty medications. The solution claims to enable four out of five patients to access medications 27% faster than traditional hub programs, with a case study showing 92% higher enrollment completion. AMP is available for specialty therapies.Business Wire BlogMcKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroadsMcKesson signed a definitive agreement to acquire RxCrossroads from CVS Health for $735 million, funded by cash on hand. The deal, expected to close in Q4 2018, adds plasma logistics and commercial services to McKesson's manufacturer offerings. McKesson expects the transaction to be approximately 20 cents accretive to adjusted earnings per diluted share by the third year.PharmaVoiceDistribution Support SystemsDavid Hileman, VP of RxCrossroads, discusses in a PharmaVOICE interview how pharmaceutical distribution channels have evolved from simple direct-to-retail and wholesale models to complex networks including specialty distributors, specialty pharmacies, and third-party logistics companies. He explains that increasingly complex biotech products with manufacturing yields as low as 70% have forced manufacturers to seek tighter inventory management through controlled distribution programs. The article cites examples such as Amgen and Wyeth's Enbrel patient-management program and Bayer's switch to a direct distribution model via Express Scripts for Prolastin to illustrate how manufacturers navigate product scarcity and reimbursement challenges.